3-amino-5-(5-bromo-1-methyl-2-oxoindolin-3-ylidene)-2-thioxothiazolidin-4-one

ID: ALA5198672

PubChem CID: 168286020

Max Phase: Preclinical

Molecular Formula: C12H8BrN3O2S2

Molecular Weight: 370.25

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1C(=O)/C(=C2/SC(=S)N(N)C2=O)c2cc(Br)ccc21

Standard InChI:  InChI=1S/C12H8BrN3O2S2/c1-15-7-3-2-5(13)4-6(7)8(10(15)17)9-11(18)16(14)12(19)20-9/h2-4H,14H2,1H3/b9-8+

Standard InChI Key:  BHDHBRWUAQYRCT-CMDGGOBGSA-N

Molfile:  

 
     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
   -1.5973   -0.6526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8827   -0.2403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1709   -0.6523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1709   -1.4773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8810   -1.8892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5973   -1.4811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6138   -1.7324    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6138   -0.3973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0988   -1.0649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8273    0.3996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3083    1.0406    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.7576    1.7324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5542    1.5189    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5974    0.6952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5440    2.5295    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.1377    2.1024    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3120    0.2826    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9240   -1.0649    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3120   -0.2400    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.8273   -2.5295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  4  7  1  0
  3  8  1  0
  8  9  1  0
  9  7  1  0
 10  8  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 10  1  0
 12 15  2  0
 13 16  1  0
 14 17  2  0
  9 18  2  0
  1 19  1  0
  7 20  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5198672

    ---

Associated Targets(Human)

PIM1 Tchem Serine/threonine-protein kinase PIM1 (9629 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Clk1 Dual specificity protein kinase CLK1 (404 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 370.25Molecular Weight (Monoisotopic): 368.9241AlogP: 1.87#Rotatable Bonds:
Polar Surface Area: 66.64Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.55CX LogP: 2.03CX LogD: 2.03
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.33Np Likeness Score: -1.20

References

1. Singh H, Agrawal DK..  (2022)  Recent advances in the development of active hybrid molecules in the treatment of cardiovascular diseases.,  62  [PMID:35364524] [10.1016/j.bmc.2022.116706]

Source